HST Global Inc. Issuance/Purchase of Shares

Issuance/Purchase of Shares of HSTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Issuance/Purchase of Shares growth rates and interactive chart.


Highlights and Quick Summary

  • Issuance/Purchase of Shares for the quarter ending December 30, 2019 was $0 (a -100.0% decrease compared to previous quarter)
  • Year-over-year quarterly Issuance/Purchase of Shares decreased by NaN%
  • Annual Issuance/Purchase of Shares for 2019 was $80 Thousand (a -78.74% decrease from previous year)
  • Twelve month Issuance/Purchase of Shares ending December 30, 2019 was $80 Thousand (a 0.0% decrease compared to previous quarter)
  • Twelve month trailing Issuance/Purchase of Shares increased by Infinity% year-over-year
Trailing Issuance/Purchase of Shares for the last four month:
30 Dec '19 29 Sep '19 30 Dec '11 30 Dec '10
$80 Thousand $80 Thousand $0 $0
Visit stockrow.com/HSTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Issuance/Purchase of Shares of HST Global Inc.

Most recent Issuance/Purchase of Sharesof HSTC including historical data for past 10 years.

Interactive Chart of Issuance/Purchase of Shares of HST Global Inc.

HST Global Inc. Issuance/Purchase of Shares for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2019 $0.0 $0.08 $0.08
2011 $0.0
2010 $0.0 $0.0 $0.0 $0.0
2009 $0.2 $0.38

Business Profile of HST Global Inc.

Sector: Medical
Industry: Drugs
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.